Guangdong Marubi Biotechnology Co Total Liabilities
Guangdong Marubi Biotechnology Co total liabilities. Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has total liabilities worth CN¥1.20 Billion CNY (≈ $174.94 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Guangdong Marubi Biotechnology Co's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guangdong Marubi Biotechnology Co (2011–2025)
Total liabilities of Guangdong Marubi Biotechnology Co from 2011 to 2025. This chart illustrates how Guangdong Marubi Biotechnology Co's total liabilities have evolved over time, based on quarterly financial data.
Guangdong Marubi Biotechnology Co Competitors by Total Liabilities
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Interroll Holding AG
SW:INRN
|
Switzerland | CHF108.31 Million |
|
Bilia AB (publ)
ST:BILI-A
|
Sweden | Skr15.91 Billion |
|
Cimpress NV
NASDAQ:CMPR
|
USA | $2.60 Billion |
|
Vistance Networks, Inc.
NASDAQ:VISN
|
USA | $991.00 Million |
|
ADIENT PLC DL-001
F:18I
|
Germany | €6.68 Billion |
|
Chacha Food Co Ltd
SHE:002557
|
China | CN¥4.04 Billion |
|
Herbalife Nutrition Ltd
F:HOO
|
Germany | €3.30 Billion |
|
Jiangsu HHCK Advanced Materials Co. Ltd. A
SHG:688535
|
China | CN¥877.12 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Guangdong Marubi Biotechnology Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Guangdong Marubi Biotechnology Co.
Liquidity & Leverage Metrics
Guangdong Marubi Biotechnology Co Total Liabilities Ratios Explained
Guangdong Marubi Biotechnology Co total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Marubi Biotechnology Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Marubi Biotechnology Co (2011–2025)
The table below shows the annual total liabilities of Guangdong Marubi Biotechnology Co from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.22 Billion ≈ $178.42 Million |
-24.55% |
| 2024-12-31 | CN¥1.62 Billion ≈ $236.48 Million |
+56.11% |
| 2023-12-31 | CN¥1.04 Billion ≈ $151.48 Million |
+23.44% |
| 2022-12-31 | CN¥838.64 Million ≈ $122.72 Million |
+39.04% |
| 2021-12-31 | CN¥603.19 Million ≈ $88.26 Million |
-24.07% |
| 2020-12-31 | CN¥794.44 Million ≈ $116.25 Million |
+3.66% |
| 2019-12-31 | CN¥766.40 Million ≈ $112.15 Million |
+4.27% |
| 2018-12-31 | CN¥735.02 Million ≈ $107.56 Million |
+14.31% |
| 2017-12-31 | CN¥643.00 Million ≈ $94.09 Million |
-0.74% |
| 2016-12-31 | CN¥647.79 Million ≈ $94.79 Million |
-0.32% |
| 2015-12-31 | CN¥649.88 Million ≈ $95.10 Million |
+8.77% |
| 2014-12-31 | CN¥597.49 Million ≈ $87.43 Million |
+22.90% |
| 2013-12-31 | CN¥486.14 Million ≈ $71.14 Million |
+3.47% |
| 2012-12-31 | CN¥469.82 Million ≈ $68.75 Million |
+4.65% |
| 2011-12-31 | CN¥448.94 Million ≈ $65.69 Million |
-- |
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands. The company was founded in 2002 and is based in Guangzhou, China.